Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

Decades of market research shows that the best-performing stocks often have an 80 or higher RS Rating in the early stages of ...

In the assessment of 12-month price targets, analysts unveil insights for Globus Medical, presenting an average target of $90 ...

“I’m proud of our team at Globus Medical, delivering incredible results ... disciplined approach to operational excellence ...